Yew Bio Pharm Cash Flow - Quarterly (OTCBB:YEWB)

Add to My Stocks
$0.2 $0 (0%) YEWB stock closing price Sep 19, 2018 (Closing)

The financial analysis of YEWB requires an investor to check the cash flows for Yew Bio Pharm. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Yew Bio Pharm profits and Yew Bio Pharm debt. Yew Bio Pharm stock analysis shows positive net income cash flow of $1.76M till 2018 Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required. The cash from operating activities for Yew Bio Pharm is $ 2018 Q2, which saw an increase from previous quarter.

View and download details of Yew Bio Pharm cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow--3.74M---8.93M8.87M8.87M5.02M
Net Increase (Decrease) in Assets Liabilities21.9M10.68M-10.28M-12.27M-10.6M-2.88M-12.82M-12.19M-11.16M-6.57M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.07M-----2.53M---
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.37M-8.24M-----0.06M-0.01M--
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities-23.68M-3.47M-0.79M-0.79M-0.67M-----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities---0.17M-------
Increase (Decrease) in Bank & Other Borrowings-1.28M-4.09M2.88M2.88M2.88M-1.21M---
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----0.1M-0.07M-0.02M-0.04M-0.04M-0.03M-0.02M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.12M-0.24M----0.01M-0.01M-0.02M-0.01M-
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year----1.15M--1.85M--
Cash & Equivalents at Year End---1.33M2.43M-----
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While Yew Bio Pharm stock price history provides the price history of a stock, Yew Bio Pharm stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Yew Bio Pharm has cash of $- on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Yew Bio Pharm stock price.
  • Yew Bio Pharm increased its cash from operating activities to $25.36M till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-24.05M for YEWB till last quarter 2018 Q2 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $-1.28M for Yew Bio Pharm. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Yew Bio Pharm Cash Flow

FCF margin